Phospholamban: a promising therapeutic target in heart failure?
AG Schmidt, I Edes, EG Kranias - Cardiovascular drugs and therapy, 2001 - Springer
Dilated cardiomyopathy and end-stage heart failure result in characteristic functional,
biochemical and molecular alterations. Multiple defects in cardiac excitation-contraction …
biochemical and molecular alterations. Multiple defects in cardiac excitation-contraction …
Phospholamban: A Promising Therapeutic Target in Heart Failure?
AG Schmidt, I Edes, EG Kranias - Cardiovascular Drugs and Therapy, 2001 - infona.pl
Dilated cardiomyopathy and end-stage heart failure result in characteristic functional,
biochemical and molecular alterations. Multiple defects in cardiac excitation-contraction …
biochemical and molecular alterations. Multiple defects in cardiac excitation-contraction …
Phospholamban: a promising therapeutic target in heart failure?
AG Schmidt, I Edes, EG Kranias - Cardiovascular Drugs and …, 2001 - europepmc.org
Dilated cardiomyopathy and end-stage heart failure result in characteristic functional,
biochemical and molecular alterations. Multiple defects in cardiac excitation-contraction …
biochemical and molecular alterations. Multiple defects in cardiac excitation-contraction …
[引用][C] Phospholamban: A promising therapeutic target in heart failure? Editorial
AG SCHMIDT, I EDES, EG KRANIAS… - … drugs and therapy, 2001 - pascal-francis.inist.fr
Phospholamban: A promising therapeutic target in heart failure? Editorial CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
Phospholamban: A Promising Therapeutic Target in Heart Failure?
AG Schmidt, I Edes, EG Kranias - Cardiovascular Drugs and Therapy, 2001 - elibrary.ru
Dilated cardiomyopathy and end-stage heart failure result in characteristic functional,
biochemical and molecular alterations. Multiple defects in cardiac excitation-contraction …
biochemical and molecular alterations. Multiple defects in cardiac excitation-contraction …
Phospholamban: A promising therapeutic target in heart failure?
AG Schmidt, I Edes, EG Kranias - Cardiovascular Drugs and …, 2001 - search.proquest.com
Dilated cardiomyopathy and end-stage heart failure result in characteristic functional,
biochemical and molecular alterations. Multiple defects in cardiac excitation-contraction …
biochemical and molecular alterations. Multiple defects in cardiac excitation-contraction …
Phospholamban: a promising therapeutic target in heart failure?
AG Schmidt, I Edes, EG Kranias - … drugs and therapy, 2001 - pubmed.ncbi.nlm.nih.gov
Dilated cardiomyopathy and end-stage heart failure result in characteristic functional,
biochemical and molecular alterations. Multiple defects in cardiac excitation-contraction …
biochemical and molecular alterations. Multiple defects in cardiac excitation-contraction …